DIVIDEND ANNOUNCEMENT: Cl A Com/Schnitzer Steel Industries Inc (NASDAQ:RDUS) on 10/25/2023 declared a dividend of $0.1875 per share

Cl A Com/Schnitzer Steel Industries Inc (NASDAQ:RDUS) on 10/25/2023 declared a dividend of $ 0.1875 per share payable on November 27, 2023 to shareholders of record as of November 13, 2023.

Cl A Com/Schnitzer Steel Industries Inc (NASDAQ:RDUS) has paid dividends since 1970, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

Cl A Com/Schnitzer Steel Industries Inc's market cap is $ 662,837,970 and has a PE ratio of 65.59. The stock price closed yesterday at $ 24.27 and has a 52 week low/high of $ 23.48 and $ 36.64.

Radius Health is a global biopharmaceutical company focused on addressing medical needs in the areas of bone health, neuroscience, and oncology. Co.'s commercial product, TYMLOS (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. Co. is also developing RAD011, a pharmaceutical-grade synthetic cannabidiol oral solution, manufactured utilizing conventional pharmaceutical manufacturing processes.

For more information on Cl A Com/Schnitzer Steel Industries Inc click here.